Arkolith/Insider Trading/ITRM/Form 4

Puttagunta Sailaja

Chief Medical OfficerIterum Therapeutics plc (ITRM) · full profile →Form 4 · filed Dec 5, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4K
Net Open-Market Flow
-$4K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 2, 2022Sell(S)3K$1.32$4K5K
Dec 1, 2022Grant(A)8K—$08K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 1, 2022Option exercise(M)8K—$025K

Transaction Codes

S
Open-market sale
A
Grant / award
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-059733) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML